Initiation and Titration of Amaryl

PHASE4CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

GLIMEPIRIDE + METFORMIN

Pharmaceutical form: Tablet Route of administration: oral Dose regimen : fixed dose combination of glimepiride / metformin: 1/250, 2/500

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Almaty

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY